Cargando…

Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial

INTRODUCTION: African adolescent girls and young women (AGYW) eligible for HIV pre‐exposure prophylaxis (PrEP) experience high levels of depressive symptoms. Depression can reduce PrEP adherence among adults, although analyses have considered depression as a time‐varying exposure rather than modelli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velloza, Jennifer, Hosek, Sybil, Donnell, Deborah, Anderson, Peter L, Chirenje, Mike, Mgodi, Nyaradzo, Bekker, Linda‐Gail, Delany‐Moretlwe, Sinead, Celum, Connie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Supplement: Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222844/ https://www.ncbi.nlm.nih.gov/pubmed/34164929 http://dx.doi.org/10.1002/jia2.25731

Ejemplares similares

Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)

The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
por: Velloza, Jennifer, et al.
Publicado: (2020)

Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)

Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?
por: Velloza, Jennifer, et al.
Publicado: (2021)

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2021)

HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
por: Celum, Connie L, et al.
Publicado: (2019)

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
por: Hosek, Sybil, et al.
Publicado: (2016)

Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial
por: Velloza, Jennifer, et al.
Publicado: (2022)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)

Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women
por: Bekker, L.G., et al.
Publicado: (2020)

Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa
por: Jewell, Britta L., et al.
Publicado: (2015)

The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa—study protocol
por: Medina-Marino, Andrew, et al.
Publicado: (2021)

Acceptability and feasibility of leveraging community‐based HIV counselling and testing platforms for same‐day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa
por: Medina‐Marino, Andrew, et al.
Publicado: (2022)

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
por: Delany-Moretlwe, Sinead, et al.
Publicado: (2022)

A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2023)

Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2023)

Factors that influence adolescent girls and young women's re‐initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa
por: de Vos, Lindsey, et al.
Publicado: (2023)

“I know why I am taking this pill”: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa
por: Daniels, Joseph, et al.
Publicado: (2023)

The impact of conditional cash transfers for HIV prevention on peer relationships: perspectives from female recipients and non-recipients in HPTN 068
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2022)

Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

Men’s perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study
por: Khoza, Makhosazane Nomhle, et al.
Publicado: (2018)

HIV and adolescents: focus on young key populations
por: Bekker, Linda-Gail, et al.
Publicado: (2015)

Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya
por: Rousseau, Elzette, et al.
Publicado: (2021)

Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe
por: Murombedzi, Caroline, et al.
Publicado: (2023)

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
por: Bekker, Linda-Gail, et al.
Publicado: (2020)

Associations between friendship characteristics and HIV and HSV‐2 status amongst young South African women in HPTN‐068
por: Fearon, Elizabeth, et al.
Publicado: (2017)

Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
por: Bekker, Linda-Gail, et al.
Publicado: (2021)

Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence
por: Giovenco, Danielle, et al.
Publicado: (2021)

PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
por: Celum, Connie L., et al.
Publicado: (2022)

Building our youth for the future
por: Bekker, Linda-Gail, et al.
Publicado: (2015)

Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women
por: O'Malley, Gabrielle, et al.
Publicado: (2021)

Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa
por: Peters, Remco P.H., et al.
Publicado: (2023)

Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research
por: Irungu, Elizabeth, et al.
Publicado: (2021)

Associations between WASH-related violence and depressive symptoms in adolescent girls and young women in South Africa (HPTN 068): a cross-sectional analysis
por: Jayaweera, Ruvani T, et al.
Publicado: (2022)

Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study)
por: Ngure, Kenneth, et al.
Publicado: (2023)

Adolescent healthcare: I’m Lovin’ it
por: Pike, Carey, et al.
Publicado: (2020)

Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis
por: Mirembe, Brenda G., et al.
Publicado: (2016)

Status of FPP Project D-082
por: Allardyce, B W
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_qb5ftts8meecl4noevosev3nqj